Project cooperationUpdated on 10 November 2025
Space-Enabled Cancer Research & Bioreactor Technologies
Co-Founder, COO at SPARK Microgravity GmbH
Munich, Germany
About
SPARK’s core mission is to advance predictive oncology by enabling cancer cell growth in orbit. Our autonomous system supports controlled culture, imaging, and data collection in microgravity — generating insights that can transform drug development.
We are looking for partners in Europe to join us in:
-
Translational oncology and cancer cell modeling
-
Bioengineering, materials, and life-support systems
-
Space data analytics, AI-driven modeling, and biological automation
SPARK offers proven hardware capabilities (TRL 7–8), system engineering expertise, and a demonstrated mission roadmap. We welcome European institutions, SMEs, and agencies interested in co-creating new research pathways bridging space and medicine.
Organisation
Similar opportunities
Investment
Invest in SPARK Microgravity: Building the Orbital Cancer Lab
Katharina Weidmann
Co-Founder, COO at SPARK Microgravity GmbH
Munich, Germany
Partnership
Seeking Partners in Space Biotech & Oncology Research
Katharina Weidmann
Co-Founder, COO at SPARK Microgravity GmbH
Munich, Germany
Expertise
In-orbit manufacturing and inspection technology development
- Equipment
- Engineering Service
- Production & Process Technologies
- Measurement, Testing, Proofing, Diagnostic Systems
- Production, Materials, Components & Semi-Finished Products
Vito Di Pietro
Business Development Manager | ESA Technology Broker at TWI Ltd - ESA Technology Broker UK
Cambridge, United Kingdom